• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有罕见ALK::SYN3融合的子宫平滑肌瘤样炎性肌纤维母细胞瘤:临床病理及分子分析

Uterine leiomyoma-like inflammatory myofibroblastic tumour with a rare ALK::SYN3 fusion: a clinicopathologic and molecular analysis.

作者信息

Ma Cao, Wei Xiaoying, Chen Zhe, Hao Xiangzhi, Sun Yuping, Zi Jie, Chu Chunyan, Zhang Lihua

机构信息

Department of Pathology, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.

Department of Pathology, Lai'an County People's Hospital, Chuzhou, China.

出版信息

Diagn Pathol. 2025 Aug 13;20(1):93. doi: 10.1186/s13000-025-01701-7.

DOI:10.1186/s13000-025-01701-7
PMID:40804412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12351933/
Abstract

Uterine inflammatory myofibroblastic tumour (IMT) is a relatively rare mesenchymal tumour of the uterus, with recurrence and metastasis rates of 25% and 2%, respectively. As IMT frequently harbours ALK gene rearrangements, some patients may benefit from treatment with tyrosine kinase inhibitors, making accurate identification of this tumour essential. Here, we report the case of a 38-year-old female patient with a tumour clinically resembling uterine leiomyoma. Microscopically, the spindled tumour cells were arranged in orderly intersecting fascicles, accompanied by a sparse infiltrate of inflammatory cells and a notable absence of myxoid matrix. Immunohistochemistry and molecular testing revealed an ALK::SYN3 fusion, suggesting the diagnosis of a uterine leiomyoma-like inflammatory myofibroblastic tumour (UL-like IMT). UL-like IMT is exceedingly rare and can easily be misdiagnosed as smooth-muscle tumours based solely on clinical manifestations and morphology. Therefore, it is recommended that the diagnosis be based on a combination of histopathological features, immunohistochemical markers, and genetic testing results to ensure a comprehensive and accurate assessment.

摘要

子宫炎性肌纤维母细胞瘤(IMT)是一种相对罕见的子宫间叶性肿瘤,复发率和转移率分别为25%和2%。由于IMT经常存在ALK基因重排,一些患者可能从酪氨酸激酶抑制剂治疗中获益,因此准确识别这种肿瘤至关重要。在此,我们报告一例38岁女性患者,其肿瘤临床上类似子宫平滑肌瘤。显微镜下,梭形肿瘤细胞呈有序交叉束状排列,伴有稀疏的炎性细胞浸润,且明显缺乏黏液样基质。免疫组织化学和分子检测显示ALK::SYN3融合,提示诊断为子宫平滑肌瘤样炎性肌纤维母细胞瘤(UL样IMT)。UL样IMT极为罕见,仅根据临床表现和形态很容易被误诊为平滑肌肿瘤。因此,建议基于组织病理学特征、免疫组化标志物和基因检测结果进行综合诊断,以确保全面准确的评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761c/12351933/b856bd481b36/13000_2025_1701_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761c/12351933/0e9eea50cb23/13000_2025_1701_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761c/12351933/4a6ed39e0df9/13000_2025_1701_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761c/12351933/b856bd481b36/13000_2025_1701_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761c/12351933/0e9eea50cb23/13000_2025_1701_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761c/12351933/4a6ed39e0df9/13000_2025_1701_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/761c/12351933/b856bd481b36/13000_2025_1701_Fig3_HTML.jpg

相似文献

1
Uterine leiomyoma-like inflammatory myofibroblastic tumour with a rare ALK::SYN3 fusion: a clinicopathologic and molecular analysis.伴有罕见ALK::SYN3融合的子宫平滑肌瘤样炎性肌纤维母细胞瘤:临床病理及分子分析
Diagn Pathol. 2025 Aug 13;20(1):93. doi: 10.1186/s13000-025-01701-7.
2
Leiomyoma-like Morphology in Metastatic Uterine Inflammatory Myofibroblastic Tumors.转移性子宫炎性肌纤维母细胞瘤的平滑肌瘤样形态学特征。
Mod Pathol. 2023 Jun;36(6):100143. doi: 10.1016/j.modpat.2023.100143. Epub 2023 Feb 18.
3
Uterine Leiomyoma-Like Inflammatory Myofibroblastic Tumor Without Myxoid Matrix or Inflammatory Cell Infiltration: A Case Report of a Potential Diagnostic Pitfall.子宫平滑肌瘤样炎症性肌纤维母细胞瘤无黏液样基质或炎性细胞浸润:潜在诊断陷阱的 1 例报告。
Int J Surg Pathol. 2024 Jun;32(4):767-771. doi: 10.1177/10668969231189170. Epub 2023 Jul 27.
4
Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion.子宫炎性肌纤维母细胞瘤:ROS1 融合的首次报道。
Genes Chromosomes Cancer. 2021 Dec;60(12):822-826. doi: 10.1002/gcc.22986. Epub 2021 Aug 5.
5
Clinical and pathological analysis of 17 cases of mesonephric-like adenocarcinoma.17例中肾样腺癌的临床与病理分析
Pathol Res Pract. 2025 Sep;273:156110. doi: 10.1016/j.prp.2025.156110. Epub 2025 Jul 18.
6
Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.含有ETV6-NTRK3融合基因的间变性淋巴瘤激酶阴性子宫炎性肌纤维母细胞瘤:一例报告
J Int Med Res. 2018 Aug;46(8):3498-3503. doi: 10.1177/0300060518780873. Epub 2018 Jun 14.
7
A Case of Inflammatory Myofibroblastic Tumor in the Abdominal Wall with Anaplastic Lymphoma Kinase and Whole Exome Sequencing Analysis.腹壁炎性肌纤维母细胞瘤伴间变性淋巴瘤激酶及全外显子测序分析1例
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0181. Epub 2025 Jul 16.
8
Cutaneous Rhabdomyosarcoma With FUS::TFCP2 Fusion: An Emerging Entity That Expands the Differential Diagnosis of ALK-Positive Spindle Cell Neoplasm of the Skin.伴有FUS::TFCP2融合的皮肤横纹肌肉瘤:一种新兴实体,扩大了皮肤ALK阳性梭形细胞瘤的鉴别诊断范围。
Am J Dermatopathol. 2025 Jun 26. doi: 10.1097/DAD.0000000000003031.
9
Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.子宫相关炎性肌纤维母细胞瘤具有独特的临床特征,并且高度富含 TIMP3-ALK 和 THBS1-ALK 融合。
Am J Surg Pathol. 2020 Jul;44(7):970-981. doi: 10.1097/PAS.0000000000001481.
10
A Novel CASC15-ALK and TFG-ROS1 Fusion Observed in Uterine Inflammatory Myofibroblastic Tumor.子宫炎性肌纤维母细胞瘤中观察到的新型 CASC15-ALK 和 TFG-ROS1 融合。
Int J Gynecol Pathol. 2023 Sep 1;42(5):451-459. doi: 10.1097/PGP.0000000000000926. Epub 2022 Dec 1.

本文引用的文献

1
Integrating clinicopathological and molecular data to assess the biological behavior of uterine inflammatory myofibroblastic tumors.整合临床病理和分子数据以评估子宫炎性肌纤维母细胞瘤的生物学行为。
Pathol Res Pract. 2025 Jun;270:155959. doi: 10.1016/j.prp.2025.155959. Epub 2025 Apr 8.
2
Uterine Inflammatory Myofibroblastic Tumors: p16 as a Surrogate for CDKN2A Deletion and Predictor of Aggressive Behavior.子宫炎性肌纤维母细胞瘤:p16 作为 CDKN2A 缺失的替代标志物和侵袭性行为的预测因子。
Am J Surg Pathol. 2024 Jul 1;48(7):813-824. doi: 10.1097/PAS.0000000000002220. Epub 2024 Apr 17.
3
Uterine Leiomyoma-Like Inflammatory Myofibroblastic Tumor Without Myxoid Matrix or Inflammatory Cell Infiltration: A Case Report of a Potential Diagnostic Pitfall.
子宫平滑肌瘤样炎症性肌纤维母细胞瘤无黏液样基质或炎性细胞浸润:潜在诊断陷阱的 1 例报告。
Int J Surg Pathol. 2024 Jun;32(4):767-771. doi: 10.1177/10668969231189170. Epub 2023 Jul 27.
4
Uterine inflammatory myofibroblastic tumor with THBS1-INSR fusion.THBS1-INSR 融合的子宫炎性肌纤维母细胞瘤。
Pathol Res Pract. 2023 Jun;246:154500. doi: 10.1016/j.prp.2023.154500. Epub 2023 May 5.
5
Leiomyoma-like Morphology in Metastatic Uterine Inflammatory Myofibroblastic Tumors.转移性子宫炎性肌纤维母细胞瘤的平滑肌瘤样形态学特征。
Mod Pathol. 2023 Jun;36(6):100143. doi: 10.1016/j.modpat.2023.100143. Epub 2023 Feb 18.
6
A Novel CASC15-ALK and TFG-ROS1 Fusion Observed in Uterine Inflammatory Myofibroblastic Tumor.子宫炎性肌纤维母细胞瘤中观察到的新型 CASC15-ALK 和 TFG-ROS1 融合。
Int J Gynecol Pathol. 2023 Sep 1;42(5):451-459. doi: 10.1097/PGP.0000000000000926. Epub 2022 Dec 1.
7
Uterine inflammatory myofibroblastic tumor.子宫炎性肌纤维母细胞瘤。
Pathol Res Pract. 2023 Feb;242:154335. doi: 10.1016/j.prp.2023.154335. Epub 2023 Jan 23.
8
Uterine Inflammatory Myofibroblastic Tumors: Proposed Risk Stratification Model Using Integrated Clinicopathologic and Molecular Analysis.子宫炎性肌纤维母细胞瘤:使用综合临床病理和分子分析的拟议风险分层模型
Am J Surg Pathol. 2023 Feb 1;47(2):157-171. doi: 10.1097/PAS.0000000000001987. Epub 2022 Nov 7.
9
Histopathologic and Molecular Characterization of Uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor: Comparison to Molecular Subtypes of Uterine Leiomyoma.子宫平滑肌瘤样炎症性肌纤维母细胞瘤的组织病理学和分子特征:与子宫平滑肌瘤分子亚型的比较。
Am J Surg Pathol. 2022 Aug 1;46(8):1126-1136. doi: 10.1097/PAS.0000000000001904. Epub 2022 Apr 18.
10
Uterine mesenchymal tumors harboring fusions and response to ALK-targeted therapy.携带融合基因的子宫间叶肿瘤及其对ALK靶向治疗的反应。
Gynecol Oncol Rep. 2021 Sep 1;37:100852. doi: 10.1016/j.gore.2021.100852. eCollection 2021 Aug.